Update: Current management issues in malignant melanoma

Paola Queirolo, Mirko Acquati, John M. Kirkwood, Alexander M.M. Eggermont, Andrea Rocca, Alessandro Testori

Onderzoeksoutput: Bijdrage aan tijdschriftArtikel recenserenpeer review

14 Citaten (Scopus)


The incidence of melanoma has increased continuously during the last decade. Surgery is the mainstay of therapy but, for patients with thick lesions or regional metastatic lymph nodes, there is a high risk of relapse. For this group of patients, there is no standard therapy or general agreement amongst oncologists. In this article, we review the current management of melanoma with regard to past completed adjuvant trials and open trials. Moreover, we discuss the role of chemotherapy in metastatic melanoma, in particular with attention to the use of fotemustine.

Originele taal-2Engels
Pagina's (van-tot)319-324
Aantal pagina's6
TijdschriftMelanoma Research
Nummer van het tijdschrift5
StatusGepubliceerd - 2005
Extern gepubliceerdJa


Duik in de onderzoeksthema's van 'Update: Current management issues in malignant melanoma'. Samen vormen ze een unieke vingerafdruk.

Citeer dit